Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Other Non-Current Liabilities (2019 - 2024)

Updated

Analysis

Aligos Therapeutics (ALGS) Other Non-Current Liabilities (2019 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 72.37 Mn
Sep 30, 2024 11.60 Mn
Jun 30, 2024 11.49 Mn
Mar 31, 2024 41.97 Mn
Dec 31, 2023 27.60 Mn
Dec 31, 2022 2.06 Bn
Sep 30, 2022 133,000.00
Jun 30, 2022 133,000.00
Mar 31, 2022 134,000.00
Dec 31, 2021 133,000.00
Sep 30, 2021 267,000.00
Jun 30, 2021 267,000.00
Mar 31, 2021 267,000.00
Dec 31, 2020 379,000.00
Sep 30, 2020 915,000.00
Dec 31, 2019 461,000.00
API Access

Aligos Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ALGS&period=max&api_key=YOUR_API_KEY